David E Ambrose
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- Carl H. June (8 shared papers)J. Joseph Melenhorst (7 shared papers)Simon F. Lacey (8 shared papers)Bruce L. Levine (6 shared papers)Michael C. Milone (2 shared papers)Stephan A. Grupp (4 shared papers)Noelle V. Frey (5 shared papers)Wei‐Ting Hwang (2 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (1 paper)Science Translational Medicine (1 paper)Cancer Research (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- United States
In The Last Decade
David E Ambrose
10 papers receiving 1.4k citations
David E Ambrose's Hit Papers
Peers
Comparison fields: 5 of 47
- Oncology 1.3k
- Immunology 405
- Genetics 141
- Genetics 342
- Biomedical Engineering 372
Countries citing papers authored by David E Ambrose
This map shows the geographic impact of David E Ambrose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E Ambrose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E Ambrose more than expected).
Fields of papers citing papers by David E Ambrose
This network shows the impact of papers produced by David E Ambrose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E Ambrose. The network helps show where David E Ambrose may publish in the future.
Co-authors
The 25 scholars most cited alongside David E Ambrose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia Hit paper breakdown → | 2015 | 1329 |
| 2 | 2016 | 36 | |
| 3 | 2013 | 19 | |
| 4 | 2016 | 15 | |
| 5 | 2016 | 15 | |
| 6 | 2022 | 6 | |
| 7 | 2020 | 6 | |
| 8 | 2018 | 3 | |
| 9 | 2017 | 1 | |
| 10 | 2017 | 1 |
About David E Ambrose
David E Ambrose is a scholar working on Oncology, Genetics, Molecular Biology, Pharmacology and Virology, having authored 10 papers that have together received 1.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), Glioma Diagnosis and Treatment (2 papers), Neurological Complications and Syndromes (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Cannabis and Cannabinoid Research (1 paper), HIV Research and Treatment (1 paper) and HIV, Drug Use, Sexual Risk (1 paper). The work is most often cited by research in Oncology (1.3k citations), Immunology (405 citations), Genetics (141 citations), Genetics (342 citations) and Biomedical Engineering (372 citations). David E Ambrose has collaborated with scholars based in United States. Frequent co-authors include Carl H. June, J. Joseph Melenhorst, Simon F. Lacey, Bruce L. Levine, Michael C. Milone, Stephan A. Grupp, Noelle V. Frey, Wei‐Ting Hwang, Zhaohui Zheng and Adam Bagg. Their work appears in journals such as Blood, Journal of Clinical Oncology, Science Translational Medicine, Cancer Research and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.